• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH CARBON DIOXIDE; ENZYMATIC, CARBON-DIOXIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH CARBON DIOXIDE; ENZYMATIC, CARBON-DIOXIDE Back to Search Results
Catalog Number 03L80-32
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/16/2024
Type of Reportable Event Malfunction
Event or Problem Description
The customer observed falsely elevated co2 results generated on the architect c16000 processing module for one sample.The customer repeated the sample on another architect and the results were lower.The following data was provided: initial result = 32 mmol/l repeat results= 25 and 26 mmol/l no impact to patient management was reported.
 
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Additional Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.A ticket search by lot indicates that the reagent lot 64248uq04 performs as expected for the product.The ticket trending review did not identify any related trends for the product for the complaint issue.A review of the device history record did not identify any non-conformances or deviations associated with the reagent lot and the complaint issue.Labeling was reviewed and adequately addresses the issue under review.Based on the investigation, no systemic issue or product deficiency of the architect carbon dioxide reagent lot 64248uq04 was identified.
 
Event or Problem Description
The customer observed falsely elevated co2 results generated on the architect c16000 processing module for one sample.The customer repeated the sample on another architect and the results were lower.The following data was provided: initial result = 32 mmol/l repeat results= 25 and 26 mmol/l no impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARBON DIOXIDE
Common Device Name
ENZYMATIC, CARBON-DIOXIDE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18789983
Report Number3002809144-2024-00048
Device Sequence Number8296980
Product Code KHS
UDI-Device Identifier00380740161538
UDI-Public00380740161538
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K060295
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/30/2024
Device Catalogue Number03L80-32
Device Lot Number64248UQ04
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/17/2024
Supplement Date Received by Manufacturer05/17/2024
Initial Report FDA Received Date02/27/2024
Supplement Report FDA Received Date05/21/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/26/2023
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC C16K PRC MOD, 03L77-01, (B)(6); ARC C16K PRC MOD, 03L77-01, (B)(6)
Patient SexUnknown
-
-